SpyGlass Pharma (SGP) Shares Outstanding (2024 - 2026)
SpyGlass Pharma (SGP) posted quarterly Shares Outstanding (Entity) of $2.2 million for Q4 2025, up 23.23% year-over-year from $1.8 million in Q4 2024, and up 23.23% quarter-over-quarter from $1.8 million in Q4 2024.
SpyGlass Pharma (SGP) Shares Outstanding (2024 - 2026) Analysis & Trends
SpyGlass Pharma (SGP) has reported Shares Outstanding (Entity) for 2 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 23.23% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (up 23.23% YoY), while the FY2025 annual figure was $2.2 million, up 23.23% from the prior year.
- Shares Outstanding (Entity) advanced to $2.2 million in Q4 2025 per SGP's latest filing, from $1.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $2.2 million in Q4 2025 and bottomed at $1.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | SpyGlass Pharma | 876.29 Mn | 876.29 Mn | - | 33.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.44 Mn |
| Dec 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 1.79 Mn |